Patient Advocate Foundation Offers New CareLine for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Patient Advocate Foundation Offers New CareLine for Hepatitis C Patients

HAMPTON, Va., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Patient Advocate Foundation (PAF) – a national, non-profit organization providing professional case management services to patients facing healthcare access issues, is pleased to announce the launch of a new Hepatitis C CareLine, providing individualized, sustained assistance to patients diagnosed with Hepatitis C.  The CareLine will provide help to patients across the country to resolve healthcare access and insurance issues, at no charge to the patient.

This new program joins Patient Advocate Foundation's existing suite of CareLine programs, furthering PAF's commitment to helping patients with chronic, debilitating or life-threatening illness navigate the healthcare industry. In 2013, Hepatitis diagnoses ranked in PAF's top ten list of diseases reported by patients seeking help through the case management team. Through the Hepatitis C CareLine, dedicated case managers will serve as a direct resource for Hepatitis C patients assisting them with benefit coordination, educational and financial resources, help accessing the latest available treatment, navigation through the appeals and reimbursement processes, as well as other patient services. This new program joins Patient Advocate Foundation's existing copayment support for Hepatitis B and Hepatitis C patients offered through its Co-Pay Relief program.

"Patient Advocate Foundation is committed to helping Hepatitis C patients maintain financial stability while consistently accessing needed treatments and prescribed medical care," says PAF CEO, Alan Balch, Ph.D.  "By directly connecting Hepatitis C patients with the correct resources and negotiating on their behalf, we believe PAF can make a difference for patients in the Hepatitis C community."

Any patient or medical provider interested in learning more about Patient Advocate Foundation's Hepatitis C CareLine should call 800-532-5274 or visit hepatitisc.pafcareline.org/ . The CareLine will offer live service to patients Monday through Thursday from 8:30 AM – 8:00 PM ET and Friday from 8:30 AM – 7:00 PM ET. Bi-lingual case managers are available to assist Spanish speaking callers.

For more information about Patient Advocate Foundation and their mission to improve healthcare access to all patients, please visit www.patientadvocate.org .

About Patient Advocate Foundation (PAF)

Patient Advocate Foundation is a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability. PAF services are available to all patients, patient families, and medical professionals without charge. Patient Advocate Foundation serves patients from all 50 states, and has physical locations at many of the top patient referral states including Texas, Florida, California, and Virginia.   

Erin Singleton, 757-952-0561

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 214

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
Q32 Bio Eyes New Horizons with Bempikibart's Potentials

Updated Category News Views 54

Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...

Continue Reading
MY DR NOW Expands: Seven-Day Clinics Open Everywhere

Updated Category News Views 29

Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...

Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution

Updated Category News Views 64

Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...

Continue Reading
Hyundai Pushes Hydrogen Boundaries at 2026 Expo

Updated Category News Views 105

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Continue Reading
Greasezilla to Process 15M Gallons of FOG Yearly

Updated Category News Views 37

Greasezilla Steps Up for FOG Processing If there’s one thing that makes dealing with wastewater a greasy business, it’s FOG - fats, oils, and grease. It’s the stuff nightmares are made of for any utility trying to keep their pipes clear and their operations running smooth. Now, Greasezilla is stepping into the spotlight at one of the country's largest wastewater...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 100

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
Camtek Hits Record Q3 Revenue; Strong Growth Ahead

Updated Category News Views 99

Camtek's Record Performance in Q3 2026 Diving straight into the numbers, Camtek (NASDAQ:CAMT) just posted a staggering $161.3 million in Q3 2026 revenues, marking a 21% jump from the previous quarter. Now, that kind of growth isn't just impressive; it's a wake-up call to any investor still snoozing on semiconductor stocks. They're looking at revenues of around $180...

Continue Reading
Sinch Partners with SpaceX's Super Intelligence Network

Updated Category News Views 101

Piecing Together the New Sinch and SpaceX Partnership Here's a juicy piece of tech news that might just tickle those investing antennas: Sinch AB's teaming up with the SpaceX Super Intelligence Network as a Marketplace Partner. Let's rip the Band-Aid off about why this development has investors riled and buzzing with expectation. Now, Sinch might not be the first company...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 28

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading

Top 5 Most Recently Viewed Articles

Akebia Develops Unique Kidney Disease Treatments for Patients

Updated Category News Views 198

Akebia's Commitment to Rare Kidney Disease Solutions In a significant advancement for the management of kidney diseases, Akebia Therapeutics, Inc. (Nasdaq: AKBA) has announced the formation of a rare kidney disease pipeline. This initiative highlights the company's sustained commitment to improve the lives of individuals affected by diverse kidney disorders. The pipeline...

Continue Reading
Enhancing Compliance: Coalfire and Vanta's Strategic Alliance

Updated Category News Views 129

Strengthening Compliance through Innovative Partnerships In an era of constant digital transformation, organizations face escalating challenges in maintaining compliance and optimizing security. The partnership between Coalfire and Vanta is strategically designed to revolutionize compliance processes, making them more efficient and less burdensome for internal teams....

Continue Reading
Free Health Screening Initiative for Heart and Kidney Risks

Updated Category News Views 181

Introducing the Heart and Kidney Health Screening Program In a significant step towards improving community health, Care Access is launching its Heart & Kidney Health Screening initiative. This program aims to raise awareness and provide essential health checks for various risk factors, particularly focusing on lipoprotein(a), commonly referred to as Lp(a). Research...

Continue Reading
Transense Technologies Director Increases Stake Significantly

Updated Category News Views 196

Director of Transense Technologies Boosts His Shareholding LONDON - Transense Technologies plc (AIM: TRT), a leading company in sensor solutions and measurement systems, has seen its Managing Director, Ryan Maughan, expand his shareholding. Recently, Maughan bought 3,025 ordinary shares at a price of 165 pence each, underscoring his confidence in the company's potential....

Continue Reading
Significant Insider Trading Alert: Century Aluminum's SVP Action

Updated Category News Views 203

Recent Insider Trading Activity at Century Aluminum Notable insider trading activity was reported recently surrounding Century Aluminum involving their Senior Vice President, Matt Aboud. The SEC filings revealed that Aboud sold an impressive 12,027 shares of the company. The total value of this transaction amounted to approximately $279,868. Market Response and Share...

Continue Reading